about
Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, MozambiqueTuberculosis and diabetes: current state and future perspectivesIncreased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature.Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort studyLiver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.State of the Art of Dual Therapy in 2015.Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort.Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.Prevalence of HIV infections in hospitalised immigrants in Clinics of Infectious Diseases in Italy: a multicentric survey.Simit epidemiological multicentric study on hospitalized immigrants in Italy during 2002.Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010.Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antCD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR.Autochthonous mucosal leishmaniasis in a hemodialyzed Italian patient.Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR.Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio.Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients.Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?Late presentation and loss to follow-up of immigrants newly diagnosed with HIV in the HAART era.Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study.Association between HLA class II antigens and hepatitis C virus infection.Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports.Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients.Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection.Are the proposed env mutations actually associated with resistance to maraviroc?Both a protective and a deleterious role for the L76V mutation.Co-receptor switch during HAART is independent of virological success.Tuberculosis and immigrants: a SIMIT (Italian Society of Infectious Diseases) clinical, epidemiological multicentric research investigation.Cervicovaginal HIV-1 shedding in pregnant women near delivery.Intrabiliary rupture of a hydatid liver cyst: a case report.Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.Low prevalence of HIV infection among immigrants within two months of their arrival in Italy.HIV-1 phenotypic susceptibility to lopinavir (LPV) and genotypic analysis in LPV/r-naive subjects with prior protease inhibitor experience.Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis.Gastrointestinal infection due to Anisakis simplex in southern Italy.
P50
Q21034056-D75B0D0E-7D6C-457B-BF4F-5888F8614EA8Q26751215-A42DAAC0-A63A-4453-ACAC-47BF9C23E308Q30869845-BF45F080-F53C-4703-A098-57A06CC01A9EQ31020119-4FBE27F1-D9D9-4FB3-9C9D-C9C88B5C516EQ33682067-B1422D4D-97F4-429D-B4CB-65A8388F0DF0Q35189562-E3702028-400F-4AAF-9C34-301494CE9122Q37605400-43F1BE27-0149-4A48-A5FD-81470B362F35Q38425305-66CC115B-597D-4005-B57E-F47BE9A561CEQ38602899-9A2F2E7F-8F89-49A1-B082-5651F4E72775Q39000397-CEDD89EB-0287-4C81-9F5D-51755741E926Q39171447-5EB161BE-DAD7-484B-83CB-27B09FDFB81FQ39365260-60A4C02E-8A27-4B2C-BEE0-045C48E42F3CQ39375437-5881A28C-36A8-48A8-86EE-4186F3F604DCQ39442292-599FFF8A-5B9E-4EF9-848F-58A627E8C0D3Q39442298-02FCB14E-66DB-4AFE-8E19-477E8596430EQ39497261-8175FD1A-77EC-4539-8044-F03C45D8976BQ39530566-8FEDB1C8-4ADC-43B4-BB16-6C55D8C73DAEQ39637061-8A00E246-5C75-445B-9BB6-A743BA016099Q40588529-B87D0952-8624-45AB-8B0E-4E6A0824221AQ41290008-41E34E41-D2D5-4C52-A2BB-491C93F9C08FQ41682247-75D6BF04-C410-4373-AA4B-053F1494CAC7Q42202541-64EE01FA-2AA2-4157-A680-A25F131BD5F1Q42231422-E57527D9-4F91-4194-B8EA-72471F9D0948Q42251208-2E158A53-5C93-4661-8742-3E88F857CE99Q42981498-2C26EA34-8C5E-4951-A8AB-D912FE626981Q42984239-B7A31B48-466C-4580-9E21-28859C95BAA3Q42991113-87A640B2-0D09-40BC-808D-5CC8A5EB4C50Q42991421-FE126884-07A2-4294-93B3-61041FC9D6C4Q42993837-D8DC13E5-EC9C-4C9B-9609-9572A89CCE4CQ43134606-BDD7EE9A-3C2E-48EB-9C74-BB7BB55C4E7CQ43153499-492DFB87-64F9-437D-812B-422912ACD271Q43255080-D447549D-30DF-418A-A9FB-33BFEEC4888BQ43460142-1DEBED90-D18F-4962-8FEF-F8308F79007FQ43802669-37E6D050-5028-401B-94A9-66FC3E04EFE2Q43815544-D2966D66-F087-424A-99AA-1703E3094FCCQ43848591-202A4DA5-6973-4F43-82A5-612879379BD5Q44496974-26AECAF3-8C16-4B4B-9956-B4CC81ED4F3FQ44517753-E27D4A28-C5AD-4B4B-BB65-7EE4607EB3D7Q44631077-588B78E7-E311-4BB6-AD06-7CF3C9F3D0DFQ44785321-3766C15D-1BB9-4917-B591-4C7E1E1BB903
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Annalisa Saracino
@ast
Annalisa Saracino
@en
Annalisa Saracino
@es
Annalisa Saracino
@nl
Annalisa Saracino
@sl
type
label
Annalisa Saracino
@ast
Annalisa Saracino
@en
Annalisa Saracino
@es
Annalisa Saracino
@nl
Annalisa Saracino
@sl
prefLabel
Annalisa Saracino
@ast
Annalisa Saracino
@en
Annalisa Saracino
@es
Annalisa Saracino
@nl
Annalisa Saracino
@sl
P1053
F-5084-2017
P106
P1153
7003735127
P21
P31
P3829
P496
0000-0001-9558-208X